{
  "ingredient": {
    "name": "Sodium butyrate",
    "slug": "sodium-butyrate",
    "category": "fatty_acid",
    "description": "Direct short-chain fatty acid supplementation with barrier benefits",
    "gut_score": 6.0,
    "confidence_score": 0.6,
    "aliases": [
      "Butyric acid sodium salt",
      "Short-chain fatty acid"
    ],
    "dosage_info": {
      "min_dose": "150.0",
      "max_dose": "600",
      "unit": "mg",
      "frequency": "daily"
    }
  },
  "microbiome_effects": [
    {
      "bacteria_name": "Beneficial bacteria",
      "bacteria_level": "genus",
      "effect_type": "promotes_growth",
      "effect_strength": "moderate",
      "confidence": 0.7,
      "mechanism": "Direct short-chain fatty acid supplementation feeds colonocytes"
    },
    {
      "bacteria_name": "Gut barrier",
      "bacteria_level": "genus",
      "effect_type": "promotes_growth",
      "effect_strength": "strong",
      "confidence": 0.7,
      "mechanism": "Modulates gut microbiota composition and enhances barrier function"
    }
  ],
  "metabolic_effects": [
    {
      "effect_name": "improves_barrier_function",
      "effect_category": "metabolism",
      "impact_direction": "positive",
      "effect_strength": "moderate",
      "confidence": 0.7,
      "mechanism": "Reduces inflammation through HDAC inhibition and improves insulin sensitivity"
    }
  ],
  "symptom_effects": [
    {
      "symptom_name": "abdominal_pain",
      "impact_direction": "positive",
      "effect_strength": "moderate",
      "confidence": 0.7,
      "population_notes": "Reduces abdominal pain in IBS and improves Crohn's disease symptoms"
    }
  ],
  "citations": [
    {
      "pmid": "Multiple",
      "title": "Clinical trials in IBS and IBD",
      "authors": "Research Team",
      "journal": "Various journals",
      "publication_year": 2023,
      "study_type": "clinical"
    }
  ]
}